Kian-Ghee Tay

PRL-3, a Metastasis Associated Tyrosine Phosphatase, Is Involved in FLT3-ITD Signaling and Implicated in Anti-AML Therapy

J. Li, Hanry Yu, Q. Zeng, 2011, PloS one.

Therapeutic potential of antisense oligodeoxynucleotides in downregulating p53 oncogenic mutations in cancers

C. Chen, Jianbiao Zhou, W. Chng, 2011, Biotechnology Letters.

Mutant nucleophosmin deregulates cell death and myeloid differentiation through excessive caspase-6 and -8 inhibition.

T. Lim, E. Koay, A. Yeoh, 2010, Blood.

Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML.

K. Glaser, S. Davidsen, Hanry Yu, 2007, Blood.

The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML.

Qiang Yu, Jianbiao Zhou, W. Chng, 2010, Blood.